Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +25.00%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.17 per share when it actually produced earnings of $0.27, delivering a surprise of +58.82%.Over the last four ...